On the basis of differentially expressed genes (DEGs) identified through the Gene Expression Omnibus (GEO) portal, it was found that elevated NEK2 gene expression was linked to drug resistance in ovarian cancer, compared to the parental counterparts [3]. The gene discussed is NEK2; the disease is ovarian carcinoma.